Vukusic S, De Seze J, Edan G, et al. Effect of MD1003 (High-Dose Biotin) for the treatment of progressive MS: 36-month follow-up data. ECTRIMS 2017, P786.
Effectiviteit en veiligheid van rituximab bij myasthenia gravis
nov 2022 | Neuro-vasculair
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen